| Aug 7 |
Top Midday Gainers
|
| Aug 7 |
G1 Therapeutics Q2 2024 Earnings Preview
|
| Aug 7 |
G1 Therapeutics surges on merger deal with Pharmacosmos
|
| Aug 7 |
Pharmacosmos Group to Acquire G1 Therapeutics
|
| Jul 31 |
Russell 2000 rise: Top 5 best, worst performers during July's rally in small-cap stocks
|
| Jul 26 |
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) top owners are retail investors with 56% stake, while 28% is held by institutions
|
| Jul 25 |
G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
|
| Jul 15 |
G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025
|
| Jul 10 |
Biotech Bombshell: G1 Therapeutics Stock Is Too Much of a Gamble
|
| Jul 1 |
G1 Therapeutics added to the Russell 2000® and 3000® Indexes
|
